Search Results 981-990 of 12349 for alp

  1. Study of Tipifarnib in Subjects With Relapsed or Refractory Peripheral T-Cell Lymphoma - Mayo Clinic

    Tipifarnib will be administered until disease progression then followed approximately every 12 weeks for survival until either death or 12 months after accrual ...

  2. Spinal fusion - Doctors & Departments - Mayo Clinic

    This procedure connects two or more bones in the spine. The bones then can't move, which helps ease neck or back pain.

  3. Arthritis - Doctors and departments - Mayo Clinic

    Learn about how different types of arthritis affect joints in different ways, along with how to get relief from arthritis pain.

  4. Pediatrics Clinical Trials - Medical Professionals

    The purpose of this study is to determine the time from intramuscular injection to the time of first fetal movement after a fetal surgery procedure. Post ...

  5. Adnexal tumors and masses - Doctors and departments - Mayo Clinic

    Learn about symptoms, diagnosis and treatment of these growths that occur in and around the ovaries and fallopian tubes.

  6. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  7. Ablation therapy - Doctors & Departments - Mayo Clinic

    Ablation therapy is a procedure used to destroy abnormal tissue. Learn about the many different conditions treated with this minimally invasive treatment.

  8. Mild Cognitive Impairment (Mci Clinical Trials - Mayo Clinic Research

    The purpose of this study is to investigate whether giving transcranial direct current stimulation (tDCS) treatment using an investigational device called the ...

  9. Olaparib in Treating Patients With Metastatic Biliary Tract Cancer With Aberrant DNA Repair Gene Mutations - Mayo Clinic

    - Alkaline phosphatase limit =< 2.5 x ULN (=< 5 x ULN for patients with liver involvement of their cancer) (obtained =< 7 days prior to registration)

  10. A Study To Assess The Feasibility And Safety Of Intratumoral Diffusing Alpha Emitters For The Treatment Of Recurrent Glioblastoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...